PRI's Focus on Health Care

View this email in your browser ([link removed])
Supreme Court and ObamaCare – here’s what to expect if law is not upheld
Featured in Fox News | Sally C. Pipes
September 28, 2020

What would a world without ObamaCare look like? The law’s defenders cry that it would be a public health catastrophe in which 20 million Americans, including many with pre-existing conditions, had their health coverage taken away from them.
Read more. . . ([link removed])

To Promote Affordability President Trump Should Empower Competition Not Socialize Healthcare
Forbes | Wayne Winegarden
September 28, 2020

According to the OECD calculations as of 2018 (the latest full dataset available), pharmaceutical expenditures comprise approximately 15.8% of the total healthcare expenditures in the average OECD country. In the U.S., pharmaceutical expenditures comprise a much smaller share of total healthcare expenditures, about 11.6%. Just as important, U.S. pharmaceutical expenditures have consistently been a smaller share of total healthcare expenditures compared to the OECD countries since 1987 (when the OECD data for the U.S. begins).
Read more. . . ([link removed])

Cleveland Is Trump’s Best Chance To Reshape The Healthcare Conversation
Forbes | Sally C. Pipes
September 28, 2020

What Biden refuses to see, and what Trump can point out, is that the federal government is a manifestly incompetent provider of coverage. Despite systematically underpaying healthcare providers, Medicare’s Part A hospital insurance trust fund will be insolvent in just four years.
Read more. . . ([link removed])

How Trump can trounce Biden on healthcare
The Washington Examiner | Sally C. Pipes
September 28, 2020

At the debate, Joe Biden will almost certainly go after President Trump for trying to invalidate the law — and ostensibly deprive millions of people of their health coverage. The president should welcome that attack. Obamacare is not worth saving. There are much better ideas for expanding access to affordable coverage.
Read more. . . ([link removed])

============================================================
** ([link removed])
** ([link removed])
** ([link removed])
** ([link removed])
** ([link removed])
Copyright © 2020 *Pacific Research Institute*, All rights reserved.
You are receiving this email because you opted in via our website.

Our mailing address is:
101 Montgomery Street, Suite 1300, San Francisco, CA 94104

Want to change how you receive these emails?
You can ** update your preferences ([link removed])
or ** unsubscribe from this list ([link removed])
.